ICOA yields 2000000.00% · JNJ yields 2.14%● Live data
📍 ICOA pulled ahead of the other in Year 1
Combined, ICOA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ICOA + JNJ for your $10,000?
ICOA, Inc. provides neutral-host wireless and wired broadband Internet services in the United States. It offers back office solutions for hotspot operators and wireless service providers. The company also provides network advisory services, as well as procures, configures, and installs network equipment; and equipment, administration, billing, business intelligence, and content management flexibility services. In addition, it engages in the design, installation, operation, maintenance, and management of neutral, common-use 802.11x standard WLAN Wi-Fi hot spot, and hot zone infrastructure facilities in airport, quick-service restaurants, universities, travel plazas, marinas, hospitality, and municipal/hot zone locations. ICOA, Inc. owns and operates approximately 1,500 broadband access installations in 45 states; the LinkSpot network in RV parks and campgrounds; and the iDockUSA network in marinas. The company was formerly known as Quintonix, Inc. and it changed its name to ICOA, Inc. in March 1989. ICOA, Inc. was founded in 1983 and is headquartered in Warwick, Rhode Island.
Full ICOA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.